Correspondence 0001213900-23-008310 from REVELATION BIOSCIENCES, INC. (REVB)
REVELATION BIOSCIENCES, INC.
Date: Feb. 6, 2023 · CIK: 0001810560 · Accession: 0001213900-23-008310
AI Filing Summary & Sentiment
Reasoning
File numbers found in text: 333-268576
Letter
Revelation Biosciences, Inc.
4660 La Jolla Village Drive
San Diego, California 92122
February 6, 2023
Via EDGAR
Securities and Exchange Commission
100 F Street, NE
Washington, DC 20549
Attention:
Daniel Crawford
Joe McCann
Re: Revelation Biosciences, Inc.
Registration Statement on Form S-1
Commission File No. 333-268576
Messrs. Crawford and McCann:
On behalf of Revelation Biosciences, Inc. (the “Company”), I hereby request that the Commission declare effective the above-captioned registration statement at 5:00pm on February 8, 2023, or as soon thereafter as practicable. Please call or email our counsel, J.P. Galda, with any further questions or comments.
Very truly yours,
Revelation Biosciences, Inc.
Show Raw Text
CORRESP
1
filename1.htm
Revelation Biosciences, Inc.
4660 La Jolla Village Drive
San Diego, California 92122
February 6, 2023
Via EDGAR
Securities and Exchange Commission
100 F Street, NE
Washington, DC 20549
Attention:
Daniel Crawford
Joe McCann
Re:
Revelation Biosciences, Inc.
Registration Statement on Form S-1
Commission File No. 333-268576
Messrs. Crawford and McCann:
On behalf of Revelation Biosciences, Inc. (the “Company”),
I hereby request that the Commission declare effective the above-captioned registration statement at 5:00pm on February 8, 2023, or as
soon thereafter as practicable. Please call or email our counsel, J.P. Galda, with any further questions or comments.
Very truly yours,
Revelation Biosciences, Inc.
/s/
Chester S. Zygmont, III
Chief
Financial Officer